We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+41.14%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$224M
AUM Growth
+$97.4M
Cap. Flow
+$66.7M
Cap. Flow %
29.82%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$66.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 78.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$1.85B
$85.2M 38.08%
+2,030,009
New +$66.7M
TTOO
2
DELISTED
T2 Biosystems, Inc
TTOO
$36.9M 16.46%
475
– –
DARE icon
3
Dare Bioscience
DARE
$18.6M
$29.6M 13.23%
27,396
– –
TRVN
4
DELISTED
Trevena, Inc.
TRVN
$24.6M 10.98%
6,031
– –
GNCA
5
DELISTED
Genocea Biosciences, Inc.
GNCA
$24.4M 10.89%
256,904
– –
FATE icon
6
Fate Therapeutics
FATE
$293M
$12.1M 5.4%
2,473,186
– –
BIND
7
DELISTED
BIND THERAPEUTICS INC
BIND
$11.1M 4.95%
2,018,253
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q1 2015 Portfolio in Review

As of Q1 2015, Polaris Venture Management Co V held 7 positions worth $224M, up 77% from $126M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V deployed $66.7M of net new capital in Q1 2015, opening 1 new position. Its largest new stake was Ocular Therapeutix: 2,030,009 shares worth $85.2M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 55% a quarter earlier.

  • Polaris Venture Management Co V's largest Q1 2015 buy was Ocular Therapeutix: 2,030,009 shares worth $85.2M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $224M portfolio in Q1 2015.
  • Polaris Venture Management Co V opened 1 new position and closed 0 in Q1 2015.
  • Polaris Venture Management Co V's portfolio value rose 77% quarter-over-quarter to $224M.

Based on Polaris Venture Management Co V's 13F filing for Q1 2015, filed 14 May 2015.